Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Feasibility and Efficacy of HABIT - a Novel Occupational Therapy Intervention for Enhancing Daily-Use of the Affected Upper Extremity Among Individuals Post Stroke.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This experimental design will assess the feasibility \& initial effectiveness of HABIT - a novel occupational therapy to increase the daily hand-use of the affected upper extremity post stroke. Assessments will be conducted at four time points: baseline, pre, post the HABIT intervention and follow-up (by phone) .

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Adults aged 18 and above residing in their own homes

• Hebrew speakers

• Up to 10 years post-stroke

• Mild upper extremity motor impairment but still report difficulty using their hand. This will be determined by a total score of 43/66, including the Hand subtest score of 7/14 points of the Fugl-Meyer Motor Assessment.

• No significant cognitive decline (score of 19 and above on Montreal Cognitive Assessment)

• Able to walk with or without assistive devices

• Able to provide informed consent by signing a consent form

• Full function of both hands and independent in daily function prior to stroke

Locations
Other Locations
Israel
Tel-Aviv University
RECRUITING
Tel Aviv
Contact Information
Primary
Debbie Rand
drand@tauex.tau.ac.il
+972-549490715
Time Frame
Start Date: 2024-06-02
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 20
Treatments
Experimental: HABIT
All participants will receive HABIT - a novel occupational therapy intervention.~HABIT will include 10 sessions (2 sessions per week for 5 weeks). HABIT will include small group of 5-8 participants, so approximately 4 rounds of HABIT will be needed to reach 20 participants
Related Therapeutic Areas
Sponsors
Leads: Tel Aviv University

This content was sourced from clinicaltrials.gov